120 related articles for article (PubMed ID: 38000668)
41. Improvement in allele-specific PCR assay with the use of polymorphism-specific primers for the analysis of minor variant drug resistance in HIV-1 subtype C.
Rowley CF; Boutwell CL; Lockman S; Essex M
J Virol Methods; 2008 Apr; 149(1):69-75. PubMed ID: 18295909
[TBL] [Abstract][Full Text] [Related]
42. Clinical, virological and biochemical evidence supporting the association of HIV-1 reverse transcriptase polymorphism R284K and thymidine analogue resistance mutations M41L, L210W and T215Y in patients failing tenofovir/emtricitabine therapy.
Betancor G; Garriga C; Puertas MC; Nevot M; Anta L; Blanco JL; Pérez-Elías MJ; de Mendoza C; Martínez MA; Martinez-Picado J; Menéndez-Arias L; ; Iribarren JA; Caballero E; Ribera E; Llibre JM; Clotet B; Jaén A; Dalmau D; Gatel JM; Peraire J; Vidal F; Vidal C; Riera M; Córdoba J; López Aldeguer J; Galindo MJ; Gutiérrez F; Álvarez M; García F; Pérez-Romero P; Viciana P; Leal M; Palomares JC; Pineda JA; Viciana I; Santos J; Rodríguez P; Gómez Sirvent JL; Gutiérrez C; Moreno S; Pérez-Olmeda M; Alcamí J; Rodríguez C; del Romero J; Cañizares A; Pedreira J; Miralles C; Ocampo A; Morano L; Aguilera A; Garrido C; Manuzza G; Poveda E; Soriano V
Retrovirology; 2012 Aug; 9():68. PubMed ID: 22889300
[TBL] [Abstract][Full Text] [Related]
43. Minority drug-resistant HIV-1 variants in treatment naïve East-African and Caucasian patients detected by allele-specific real-time PCR.
Ekici H; Amogne W; Aderaye G; Lindquist L; Sönnerborg A; Abdurahman S
PLoS One; 2014; 9(10):e111042. PubMed ID: 25333961
[TBL] [Abstract][Full Text] [Related]
44. Surveillance of antiretroviral drug resistance mutations in untreated young children living in the Central African Republic.
Charpentier C; Gody JC; Tisserand P; Matta M; Péré H; Fournier J; Mbitikon O; Bélec L
Antivir Ther; 2011; 16(8):1347-50. PubMed ID: 22155917
[TBL] [Abstract][Full Text] [Related]
45. Clinical significance of HIV reverse-transcriptase inhibitor-resistance mutations.
Ibe S; Sugiura W
Future Microbiol; 2011 Mar; 6(3):295-315. PubMed ID: 21449841
[TBL] [Abstract][Full Text] [Related]
46. Prevalence of genotypic resistance to nucleoside analogues, nonnucleoside analogues, and protease inhibitors in HIV-infected persons in Athens, Greece.
Panos G; Charatsis G; Paparizos V; Kazantzi M; Falagas ME
AIDS Res Hum Retroviruses; 2008 Jan; 24(1):43-51. PubMed ID: 18275347
[TBL] [Abstract][Full Text] [Related]
47. Characteristics of drug resistance in HIV-1 CRF55_01B from ART-experienced patients in Guangdong, China.
Lan Y; Xin R; Cai W; Deng X; Li L; Li F; Cai X; Tang X; Fan Q; Hu F
J Antimicrob Chemother; 2020 Jul; 75(7):1925-1931. PubMed ID: 32300784
[TBL] [Abstract][Full Text] [Related]
48. HIV type 1 pol gene diversity and antiretroviral drug resistance mutations in Santos, Brazil.
de Sa-Filho DJ; Soares Mda S; Candido V; Gagliani LH; Cavaliere E; Diaz RS; Caseiro MM
AIDS Res Hum Retroviruses; 2008 Mar; 24(3):347-53. PubMed ID: 18327988
[TBL] [Abstract][Full Text] [Related]
49. Comparison of an
Tzou PL; Ariyaratne P; Varghese V; Lee C; Rakhmanaliev E; Villy C; Yee M; Tan K; Michel G; Pinsky BA; Shafer RW
J Clin Microbiol; 2018 Jun; 56(6):. PubMed ID: 29618499
[TBL] [Abstract][Full Text] [Related]
50. Characterization of HIV drug resistance mutations among patients failing first-line antiretroviral therapy from a tertiary referral center in Lusaka, Zambia.
Seu L; Mulenga LB; Siwingwa M; Sikazwe I; Lambwe N; Guffey MB; Chi BH
J Med Virol; 2015 Jul; 87(7):1149-57. PubMed ID: 25754408
[TBL] [Abstract][Full Text] [Related]
51. Comparison of HIV drug resistance profiles across HIV-1 subtypes A and D for patients receiving a tenofovir-based and zidovudine-based first line regimens in Uganda.
Ayitewala A; Kyeyune F; Ainembabazi P; Nabulime E; Kato CD; Nankya I
AIDS Res Ther; 2020 Jan; 17(1):2. PubMed ID: 32005262
[TBL] [Abstract][Full Text] [Related]
52. Virologic failures on initial boosted-PI regimen infrequently possess low-level variants with major PI resistance mutations by ultra-deep sequencing.
Lataillade M; Chiarella J; Yang R; DeGrosky M; Uy J; Seekins D; Simen B; St John E; Moreno E; Kozal M
PLoS One; 2012; 7(2):e30118. PubMed ID: 22355307
[TBL] [Abstract][Full Text] [Related]
53. Diagnostic Accuracy of Pan-Degenerate Amplification and Adaptation Assay for HIV-1 Drug Resistance Mutation Analysis in Low- and Middle-Income Countries.
Kouamou V; Manasa J; Katzenstein D; McGregor AM; Ndhlovu CE; Makadzange T
J Clin Microbiol; 2020 Aug; 58(9):. PubMed ID: 32522826
[TBL] [Abstract][Full Text] [Related]
54. Molecular basis of the association of H208Y and thymidine analogue resistance mutations M41L, L210W and T215Y in the HIV-1 reverse transcriptase of treated patients.
Betancor G; Nevot M; Mendieta J; Gómez-Puertas P; Martínez MA; Menéndez-Arias L
Antiviral Res; 2014 Jun; 106():42-52. PubMed ID: 24667336
[TBL] [Abstract][Full Text] [Related]
55. Structural analysis of reverse transcriptase mutations at codon 215 explains the predominance of T215Y over T215F in HIV-1 variants selected under antiretroviral therapy.
Yahi N; Fantini J; Henry M; Tourrès C; Tamalet C
J Biomed Sci; 2005 Oct; 12(5):701-10. PubMed ID: 16200350
[TBL] [Abstract][Full Text] [Related]
56. Near-point-of-care assay with a visual readout for detection of HIV-1 drug resistance mutations: A proof-of-concept study.
Gomez-Martinez J; Foulongne V; Laureillard D; Nagot N; Montès B; Cantaloube JF; Van de Perre P; Fournier-Wirth C; Molès JP; Brès JC
Talanta; 2021 Aug; 231():122378. PubMed ID: 33965042
[TBL] [Abstract][Full Text] [Related]
57. Rapid and Simultaneous Detection of Major Drug Resistance Mutations in Reverse Transcriptase Gene for HIV-1 CRF01_AE, CRF07_BC and Subtype B in China Using Sequenom MassARRAY® System.
Cheung KW; Peng Q; He L; Cai K; Jiang Q; Zhou B; To SW; Yam WC; Liu L; Chen Z; Wang H
PLoS One; 2016; 11(4):e0153641. PubMed ID: 27092551
[TBL] [Abstract][Full Text] [Related]
58. Evaluation of a benchtop HIV ultradeep pyrosequencing drug resistance assay in the clinical laboratory.
Avidor B; Girshengorn S; Matus N; Talio H; Achsanov S; Zeldis I; Fratty IS; Katchman E; Brosh-Nissimov T; Hassin D; Alon D; Bentwich Z; Yust I; Amit S; Forer R; Vulih Shultsman I; Turner D
J Clin Microbiol; 2013 Mar; 51(3):880-6. PubMed ID: 23284027
[TBL] [Abstract][Full Text] [Related]
59. Drug resistance mutations in HIV pol sequences from Argentinean patients under antiretroviral treatment: subtype, gender, and age issues.
Jones LR; Moretti F; Calvo AY; Dilernia DA; Manrique JM; Gómez-Carrillo M; Salomón H
AIDS Res Hum Retroviruses; 2012 Aug; 28(8):949-55. PubMed ID: 21936717
[TBL] [Abstract][Full Text] [Related]
60. Minority HIV-1 resistant variants in recent infection and in patients who failed first-line antiretroviral therapy with no detectable resistance-associated mutations in Thailand.
Le Nguyen H; Pitakpolrat P; Sirivichayakul S; Delaugerre C; Ruxrungtham K
J Med Virol; 2012 May; 84(5):713-20. PubMed ID: 22431018
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
